Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vladimir Stepanov

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Harm Reduction Journal|January 20, 2021
More evidence or stronger political will: exploring the feasibility of needle and syringe programs in Ukrainian prisonsAlexandra Dmitrieva, Vladimir Stepanov, Kateryna Svyrydova, et al.
Nuclear Medicine and Biology|December 26, 2016
Development of [<sup>11</sup>C]/[<sup>3</sup>H]THK-5351 - A potential novel carbon-11 tau imaging PET radioligandVladimir Stepanov, Marie Svedberg, Zhisheng Jia, et al.
Neuropharmacology|October 8, 2019
The pro-psychotic metabotropic glutamate receptor compounds fenobam and AZD9272 share binding sites with monoamine oxidase-B inhibitors in humansKatarina Varnäs, Zsolt Cselényi, Ryosuke Arakawa, et al.
Nuclear Medicine and Biology|December 3, 2014
Characterization of the binding properties of T-773 as a PET radioligand for phosphodiesterase 10AAkina Harada, Kazunori Suzuki, Shotaro Miura, et al.
Current Radiopharmaceuticals|December 31, 2016
Development of a Novel Carbon-11 Labeled PET Radioligand for Melanin- Concentrating Hormone Receptor 1Hideyuki Igawa, Vladimir Stepanov, Lenke Tari, et al.
Neuroimage|July 18, 2016
A human [(11)C]T-773 PET study of PDE10A binding after oral administration of TAK-063, a PDE10A inhibitorAkihiro Takano, Per Stenkrona, Vladimir Stepanov, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 20, 2019
Effect of clinically relevant doses of vortioxetine and citalopram on serotonergic PET markers in the nonhuman primate brainKai-Chun Yang, Vladimir Stepanov, Nahid Amini, et al.
Plos One|February 10, 2021
Correction: Is no test better than a bad test: Impact of diagnostic uncertainty on the spread of COVID-19Nicholas Gray, Dominic Calleja, Alexander Wimbush, et al.
Plos One|October 21, 2020
Is "no test is better than a bad test"? Impact of diagnostic uncertainty in mass testing on the spread of COVID-19Nicholas Gray, Dominic Calleja, Alexander Wimbush, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 19, 2011
Imaging of the striatal and extrastriatal dopamine transporter with (18)F-LBT-999: quantification, biodistribution, and radiation dosimetry in nonhuman primatesAndrea Varrone, Vladimir Stepanov, Ryuji Nakao, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Harm Reduction Journal|January 20, 2021
More evidence or stronger political will: exploring the feasibility of needle and syringe programs in Ukrainian prisonsAlexandra Dmitrieva, Vladimir Stepanov, Kateryna Svyrydova, et al.
Nuclear Medicine and Biology|December 26, 2016
Development of [<sup>11</sup>C]/[<sup>3</sup>H]THK-5351 - A potential novel carbon-11 tau imaging PET radioligandVladimir Stepanov, Marie Svedberg, Zhisheng Jia, et al.
Neuropharmacology|October 8, 2019
The pro-psychotic metabotropic glutamate receptor compounds fenobam and AZD9272 share binding sites with monoamine oxidase-B inhibitors in humansKatarina Varnäs, Zsolt Cselényi, Ryosuke Arakawa, et al.
Nuclear Medicine and Biology|December 3, 2014
Characterization of the binding properties of T-773 as a PET radioligand for phosphodiesterase 10AAkina Harada, Kazunori Suzuki, Shotaro Miura, et al.
Current Radiopharmaceuticals|December 31, 2016
Development of a Novel Carbon-11 Labeled PET Radioligand for Melanin- Concentrating Hormone Receptor 1Hideyuki Igawa, Vladimir Stepanov, Lenke Tari, et al.
Neuroimage|July 18, 2016
A human [(11)C]T-773 PET study of PDE10A binding after oral administration of TAK-063, a PDE10A inhibitorAkihiro Takano, Per Stenkrona, Vladimir Stepanov, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 20, 2019
Effect of clinically relevant doses of vortioxetine and citalopram on serotonergic PET markers in the nonhuman primate brainKai-Chun Yang, Vladimir Stepanov, Nahid Amini, et al.
Plos One|February 10, 2021
Correction: Is no test better than a bad test: Impact of diagnostic uncertainty on the spread of COVID-19Nicholas Gray, Dominic Calleja, Alexander Wimbush, et al.
Plos One|October 21, 2020
Is "no test is better than a bad test"? Impact of diagnostic uncertainty in mass testing on the spread of COVID-19Nicholas Gray, Dominic Calleja, Alexander Wimbush, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 19, 2011
Imaging of the striatal and extrastriatal dopamine transporter with (18)F-LBT-999: quantification, biodistribution, and radiation dosimetry in nonhuman primatesAndrea Varrone, Vladimir Stepanov, Ryuji Nakao, et al.
Pageof 5